Heart Disease :: Pfizer’s Lipitor for 5 new indications in patients with heart disease
Pfizer announced that the U.S. Food and Drug Administration (FDA) has approved Lipitor? (atorvastatin calcium) Tablets to reduce the risk of nonfatal heart attacks, fatal and non-fatal strokes, certain types of heart surgery, hospitalization for heart failure, and chest pain in patients with heart disease.